Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MON4STRAT meropenem optimization study in ventilated adults with Gram-negative lower respiratory tract infection
2018-000450-21Phase 4Terminated
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meropenem in hospital-acquired pneumonia (HAP) and tracheobronchitis (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: PK/PD target attainment over treatment course. Started Feb 2018; status: terminated.
02
Drugs
meropenem
03
Conditions
hospital-acquired pneumonia (HAP)tracheobronchitis
Beyond the preview
Go deeper on 2018-000450-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000450-21.